• Tidak ada hasil yang ditemukan

suppmat1559.doc 198KB Jun 05 2011 09:30:54 PM

N/A
N/A
Protected

Academic year: 2017

Membagikan "suppmat1559.doc 198KB Jun 05 2011 09:30:54 PM"

Copied!
8
0
0

Teks penuh

(1)
[image:1.612.73.561.183.728.2]

SUPPLEMENTARY MATERIAL Table 4

Multiple Amino-Acid Sequence Alignment for 45 Class A -Lactamases (Positions 214 and 233

are marked by asterisks)

Source 200 210 Amino Acid Position220 230

(2)
(3)
[image:3.792.75.713.136.389.2]

Table 5

Calculated pKa and pKint for Some Titratable Residues from the Active Site of E. coli TEM-1 (1btl).

Parameter Set His tauto-merism

εin pI pKa(pKint)

Ser-70 (A) Lys-73 (C) Glu-166 (A) Lys-234 (C) Arg-244 (C) Asp-214 (A) Asp-233 (A)

AMBER91 Yes 20 4.65 23.7 (12.7) 13.5 (7.89) 0.561 (3.39) 9.31 (7.44) 11.7 (9.73) 1.92 (3.26) -2.02 (2.16) AMBER91 Yes 4 4.49 >30 (13.3) 13.9(.0043) -0.004 (3.98) -5.53 (-2.11) 5.53 (4.25) 29.8 (5.67) <-10 (-.095) CHARMM22 Yes 20 5.17 26.0 (15.2) 18.1 (10.9) 2.64 (5.64) 13.5 (10.8) 14.8 (12.3) 5.18 (5.34) -0.55 (3.72) CHARMM22 Yes 4 5.65 22.3 (20.2) >30 (10.3) 2.46 (11.2) 9.78 (10.0) 13.1 (11.5) >30 (12.3) -8.50 (4.76) PARSE3 No 20 5.04 23.8 (14.8) 15.7 (10.2) 2.91 (5.03) 12.9 (10.4) 16.1 (13.1) 3.37 (5.15) 0.901 (5.49) PARSE3 No 4 5.34 >21.5 (18.5) >30 (7.40) 6.29 (9.80) 7.51 (8.09) 19.8 (15.8) 17.2 (12.3) -2.61 (14.0) AMBER91 No 20 4.46 23.8 (12.7) 13.5 (7.77) 0.627 (3.27) 9.19 (7.27) 11.6 (9.67) 0.858 (3.08) -1.06 (2.68) AMBER91 No 4 4.07 >30 (13.3) 15.3 (-0.63) -0.528 (3.52) <-10 (-2.74) 5.47 (4.14) 13.0 (5.39) -7.38 (2.83) CHARMM22 No 20 5.16 26.1 (15.3) 17.5 (10.6) 2.77 (5.16) 13.5 (10.5) 14.8 (12.3) 3.79 (5.16) 0.745 (4.66) CHARMM22 No 4 5.67 22.7 (20.5) >30 (9.03) 3.85 (9.88) 8.11 (8.48) 13.3 (11.4) ≈22 (12.0) -3.22 (9.90) AMBER94 No 20 5.06 24.9 (15.0) 16.6 (10.4) 2.85 (4.80) 13.3 (10.4) 28.2 (19.4) 3.32 (5.00) 0.445 (4.46) AMBER94 No 4 5.09 21.2 (19.4) >30 (7.99) 2.82 (8.07) 17.3 (8.34) >30 (47.2) 17.3 (11.3) -4.02 (9.01)

(4)

Calculated pKa and pKint for Some Titratable Residues from the Active Site of B. licheniformis 749/C Wild Type (4blm) and Glu166Ala

Mutant (1mbl) Compared with E. coli TEM-1 (1btl).

Enzyme εin pI pKa (pKint)

Ser-70 (A) Lys-73 (C) Glu-166 (A) Lys-234 (C) Arg-244 (C) Asp-214 (A) Asp-233 (A) BCL w.t. 20 4.56 25.2 (14.9) 17.1 (10.6) 2.28 (4.64) 14.2 (10.6) 17.4 (11.9) Asn-214 -0.771 (3.99) BCL w.t. 4 4.99 26.1 (19.3) >30 (9.56) 1.43 (7.73 13.6 (9.09) 20.4 (9.76) Asn-214 -8.39 (6.63) BCL E166A 20 4.54 20.0 (14.2) 12.6 (10.2) Ala-166 14.1 (10.4) 17.1 (11.7) Asn-214 -0.972 (3.96) BCL E166A 4 4.87 10.0 (16.2) 28.6 (8.49) Ala-166 18.7 (8.34) 18.9 (9.36) Asn-214 -8.96 (6.80) TEM-1 20 5.06 24.9 (15.0) 16.6 (10.4) 2.85 (4.80) 13.3 (10.4) 28.2 (19.4) 3.32 (5.00) 0.445 (4.46) TEM-1 4 5.09 21.2 (19.4) >30 (7.99) 2.82 (8.07) 17.3 (8.34) >30 (47.2) 17.3 (11.3) -4.02 (9.01)

[image:4.792.68.735.155.304.2]
(5)
[image:5.792.56.716.156.324.2]

Table 7

Calculated pKa and pKint for Some Titratable Residues from the Active Site of S. aureus PC1 Wild Type (3blm) and Lys73His Mutant

(1dja) Compared with E. coli TEM-1 (1btl).

Enzyme εin pI

pKa (pKint)

Ser-70 (A) Lys-73(C) Glu-166 (A) Lys-234 (C) Arg-244 (C) Asp-214 (A) Asp-233 (A) SA PC1 20 10.0 24.3 (14.8) 17.9 (10.7) 1.01 (4.50) 14.2 (10.5) >30 (19.1) Asn-214 0.027 (4.66) SA PC1 4 9.52 21.5 (18.9) >30 (9.96) -1.32 (6.92) 13.6 (916) >30 (45.3) Asn-214 -3.22 (9.62)

His-73 (H; H )

SA PC1 K73H 20 ND 25.3 (16.3) 6.87 (6.03; 6.05) 0.614 (6.14) 17.2 (12.4) 17.4 (12.5) Asn-214 1.07 (5.23) SA PC1 K73H 4 ND >30 (23.4) 8.01 (2.08; 3.47) -3.34 (13.2) 26.4 (15.9) 16.9 (10.5) Asn-214 ~-1 (11.4)

Lys-73(C)

TEM-1 20 5.06 24.9 (15.0) 16.6 (10.4) 2.85 (4.80) 13.3 (10.4) 28.2 (19.4) 3.32 (5.00) 0.445 (4.46) TEM-1 4 5.09 21.2 (19.4) >30 (7.99) 2.82 (8.07) 17.3 (8.34) >30 (47.2) 17.3 (11.3) -4.02 (9.01)

(6)

Calculated pKa and pKint for Some Titratable Residues from the Active Site of the Model of the Michaelis Complex of E. coli TEM-1,

B. licheniformis 749/C Wild Type, its Glu166Ala Mutant, S. aureus PC1 Wild Type and its Lys73His Mutant with Penicillin G.

Enzyme εin

pKa (pKint)

Ser-70 (A) Lys-73(C) Glu-166 (A) Lys-234 (C) Arg-244 (C) Asp-214 (A) Asp-233 (A)

TEM-1 (91) 20 27.9 (12.4) 16.1 (7.02) -0.662 (2.72) 12.5 (6.91) 13.9 (9.15) 2.05 (3.07) -1.57 (2.57) TEM-1 (91) 4 >28 (13.2) >30 (-5.56) -8.21 (1.96) 3.80 (-6.19) 10.7 (-.35) >17 (5.12) -9.95 (2.03)

TEM-1 20 29.5 (15.4) 17.9 (9.96) 0.785 (4.15) 18.5 (10.9) 23.5 (16.1) 4.93 (5.40) 0.213 (4.59) TEM-1 4 >30 (25.0) >30 (6.35) -1.72 (6.88) >30 (10.2) >30 (29.4) 16.3 (13.2) -4.34 (9.54)

BCL w.t. 20 >30 (15.5) 19.4 (10.6) 0.669 (4.07) 19.5 (10.7) 19.6 (11.7) Asn-214 3.82 (3.48) BCL w.t. 4 >30 (25.0) >30 (9.19) -2.95 (6.23) >30 (9.34) 26.6 (8.60) Asn-214 <-10 (4.36)

BCL E166A mutant 20 26.9 (15.1) 14.7 (10.5) Ala-166 19.6 (10.6) 19.2 (11.8) Asn-214 -2.52 (3.38) BCL E166A mutant 4 >23 (23.4) 22.4 (8.67) Ala-166 >30 (8.74) 26.6 (8.78) Asn-214 <-10 (3.76)

SA w.t. 20 >30 (15.4) 19.8 (10.1) -0.703 (4.14) 19.6 (10.3) 19.7 (11.8) Asn-214 -2.36 (4.03) SA w.t. 4 >30 (24.4) >30 (6.70) <-10 (6.46) >30 (7.46) 23.1 (8.00) Asn-214 <-10 (6.59)

His-73 (H; H)

[image:6.792.74.680.170.495.2]
(7)
[image:7.612.72.541.158.517.2]

Table 9

Calculated pKa and pKint for Some Titratable Residues from the Active Site of the Intact Enzyme P99 E.

cloacae (2blt) and a Model of its Michaelis Complex with Penicillin G.

Enzyme form

His tauto-merism

εin pI Parameter Set pKa (pKint)

Ser-64 (A) Lys-67 (C) Tyr-150 (A) Lys-315 (C)

Intact Yes 20 7.14 AMBER91 27.2 (13.1) 13.6 (8.09) 6.07 (9.92) 14.1 (8.28) Intact Yes 4 5.84 AMBER91 >30 (14.2) -5.64 (0.607) 23.0 (12.1) 6.68 (3.15) Intact Yes 20 8.45 CHARMM22 26.0 (14.5) 15.4 (9.70) 7.76 (12.1) 21.7 (10.7) Intact Yes 4 7.77 CHARMM22 >20 (17.1) -1.49 (5.18) >18 (18.4) >14 (10.2) Intact No 20 6.46 AMBER91 26.5 (12.3) 14.3 (7.24) 5.23 (9.01) 12.2 (7.18) Intact No 4 4.88 AMBER91 >30 (12.8) -5.93 (-1.02) 21.2 (10.3) 4.17 (.811) Intact No 20 8.49 AMBER94 25.8 (14.4) 15.0 (9.40) 8.12 (11.5) 19.6 (10.5) Intact No 4 7.60 AMBER94 >30 (16.9) -3.52 (3.96) 12.9 (16.2) >30 (9.43) Intact No 20 8.45 CHARMM22 26.5 (14.5) 15.1 (9.51) 7.76 (11.6) 20.3 (10.5) Intact No 4 7.69 CHARMM22 ≈26.3 (17.1) -2.76 (4.32) 14.7 (16.7) >30 (9.57) Intact No 20 8.63 PARSE3 23.1 (14.0) 12.4 (9.66) 8.36 (11.4) 19.8 (10.7) Intact No 4 7.64 PARSE3 23.5 (15.5) -1.01 (5.51) 13.6 (16.1) >30 (10.6) Michaelis No 20 ND AMBER91 >30 (13.8) 18.8 (8.68) 10.4 (9.52) 25.0 (7.56) Michaelis No 4 ND AMBER91 >30 (19.7) 4.97 (2.17) >30 (11.0) ≈30 (-1.38) Michaelis No 20 ND AMBER94 >30 (16.2) 20.6 (10.7) 12.2 (12.0) 26.8 (10.6) Michaelis No 4 ND AMBER94 >30 (28.4) 12.2 (9.95) 19.1 (19.5) >30 (9.71)

E. cloacae P99 pI = 8.2; 7.8; 8.3; 8.25; 8.95 (Goering, R. V.; Sanders, C. C.; Sanders, W. E., Jr.; Guay, R.; Guerin, S. Rev. Infect. Dis. 1988, 10, 786-792; Goward, C. R.; Stevens, G. B.; Hammond, P. M.; Scawen, M. D. Chromatogr. 1988, 457, 317-324; Minami, S.; Inoue, M.; Mitsuhashi, S. Antimicrob. Agents. Chemother. 1980, 18, 853-857; Seeberg, A. H.; Tolxdorff-Neutzling, R. M.; Wiedemann, B. Antimicrob. Agents. Chemother. 1983, 23, 918-925.)

(8)

Calculated pKa and pKint for Some Titratable Residues from the Active Site of the

DD-Transpeptidase R61 Streptomyces sp. (1cef) and a Model of its Michaelis Complex with

Penicillin G.

Enzyme His tau- to- me-rism

εin pI Parameter

Set

pKa (pKint)

Ser-62 (A) Lys-65 (C) Tyr-159 (A) His-298 (C)

Intact No 20 4.44 AMBER91 ≈29.5 (13.2) 18.1 (8.38) 7.69 (10.2) -1.37 (3.79) Intact No 4 4.02 AMBER91 >30 (14.0) -1.97 (1.71) 27.0 (13.0) <-10 (-3.44) Intact No 20 4.89 CHARMM22 >30 (14.5) 23.6 (10.3) 9.21 (11.6) 2.11 (6.39) Intact No 4 5.22 CHARMM22 >30 (17.0) 13.1 (7.98) 7.84 (17.3) -5.20 (6.92) Intact No 20 4.71 PARSE3 28.3 (14.1) 21.9 (10.3) 9.31 (11.4) 1.56 (6.24) Intact No 4 4.67 PARSE3 18.5 (14.7) 8.55 (8.45) >24 (16.5) -7.08 (5.43) Intact No 20 4.85 AMBER94 ≈30 (14.3) 21.8 (10.1) 9.23 (11.2) 1.38 (5.78) Intact No 4 4.92 AMBER94 27.9 (16.2) 12.9 (7.27) 7.48 (15.1) -6.63 (4.25) Intact Yes 20 ND AMBER94 >30 (16.4) 20.5 (12.6) 9.20 (13.7) 2.27 (7.94;7.26) Intact Yes 4 ND AMBER94 29.8 (21.3) ~10.5 (15.7) 6.92 (22.6) -5.89 (9.72; 8.22)

Michaelis No 20 ND AMBER91 >30 (13.2) 24.7 (8.30) 14.1 (9.82) -3.58 (1.36) Michaelis No 4 ND AMBER91 >30 (16.1) 5.81 (-0.21) >30 (12.6) <-10 (-16.0) Michaelis No 20 ND AMBER94 >30 (14.8) 25.8 (9.99) 13.8 (11.4) -2.32 (3.17) Michaelis No 4 ND AMBER94 >30 (21.0) 20.7 (6.02) >30 (17.3) <-10 (-9.27) Michaelis Yes 20 ND AMBER94 >30 (17.8) 25.9 (12.9) 15.6 (14.2) -0.334 (5.51;6.07) Michaelis Yes 4 ND AMBER94 >30 (33.1) >18 (18.1) >30 (28.4) <-10 (-2.47;1.96)

[image:8.612.77.558.185.577.2]

Gambar

Table 4Multiple Amino-Acid Sequence Alignment for 45 Class A -Lactamases (Positions 214 and 233
Table 5Calculated pKa and pKint for Some Titratable Residues from the Active Site of E
Table 6Calculated pKa and pKint for Some Titratable Residues from the Active Site of B
Table 7Calculated pKa and pKint for Some Titratable Residues from the Active Site of S
+4

Referensi

Dokumen terkait

- Calon Penyedia barang dan jasa yang telah mendaftar pada paket pekerjaan. Pemagaran Gedung Kantor dan ikut secara on line di

Panitia Pengadaan Barang dan Jasa Dinas Pendapatan Kota Batu Tahun Anggaran 2012,.. bersama ini mengumumkan Pemenang Penunjukan Langsung untuk Pekerjaan Pengadaan

Berdasarkan hasil evaluasi penawaran yang dituangkan dalam Berita Acara Evaluasi Penawaran Pengadaaan Pakaian Seragam &amp; Kelengkapan Atribut Mahasiswa Poltekkes

Kurangnya pengetahuan tentang penyakit, prognosis dan pengobatan berhubungan dengan kurangnya informasi, misinterpretasi, keterbatasan kognitif ditandai dengan sering

Implementasi adalah proses penerapan rancangan program yang telah dibuat pada bab sebelumnya atau aplikasi dalam melaksanakan sistem informasi pemrograman yang

Dengan metode plebotomi, yaitu suatu prosedur yang bermanfaat pada pasien dengan edema pulmonal akut karena tindakan ini dengan segera memindahkan volume darah dari sirkulasi

Pokja I Unit Layanan Pengadaan.

Tipe sekunder : terdiri dari penyakit otot jantung dengan sebab yang diketahui atau berhubungan dengan penyakit yang mengenai sisitem organ